☆ 4.8 Letter

Chimeric Antigen Receptor T-Cell Therapy-Associated Cardiomyopathy in Patients With Refractory or Relapsed Non-Hodgkin Lymphoma

CIRCULATION (2020)

Get Full Text
Add to Collection

Journal

CIRCULATION
Volume 142, Issue 17, Pages 1687-1690

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCULATIONAHA.120.048100

Keywords

axicabtagene ciloleucel; chimeric antigen receptor T-cell therapy; cardiomyopathy; cardiotoxicity; cytokine release syndrome; heart failure; lymphoma; non-Hodgkin; receptors; chimeric antigen; tisagenlecleucel

Categories

Cardiac & Cardiovascular Systems Peripheral Vascular Disease

Funding

  1. Gelb Master Clinician Award

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.